Copyright © 2021 Pharmascimed. All Rights Reserved.
esketamine
FDA set to vote on Jannsen’s depression drug
- February 11, 2019
- 0
The U.S. FDA are set to debate the viability of Johnson & Johnson's esketamine spray for major depression - a medication related to 'party drug' ketamine. Votes from the FDA's advisory committee...
Read moreTrending
Recent Posts
The coming age of biosimilars
- February 26, 2019
- 0
Novartis acquires game-changing cardiovascular therapy
- February 25, 2019
- 0
Roche buys gene therapy company Spark for $4.3bn
- February 25, 2019
- 0
AbbVie and Voyager Therapeutics in Parkinson’s Pact
- February 22, 2019
- 0